SG11201805810PA - Extended, delayed and immediate release formulation method of manufacturing and use thereof - Google Patents
Extended, delayed and immediate release formulation method of manufacturing and use thereofInfo
- Publication number
- SG11201805810PA SG11201805810PA SG11201805810PA SG11201805810PA SG11201805810PA SG 11201805810P A SG11201805810P A SG 11201805810PA SG 11201805810P A SG11201805810P A SG 11201805810PA SG 11201805810P A SG11201805810P A SG 11201805810PA SG 11201805810P A SG11201805810P A SG 11201805810PA
- Authority
- SG
- Singapore
- Prior art keywords
- delayed
- extended
- manufacturing
- immediate release
- release formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
- A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/842,509 US10105330B2 (en) | 2012-01-04 | 2015-09-01 | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
PCT/US2016/041352 WO2017039832A1 (en) | 2015-09-01 | 2016-07-07 | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201805810PA true SG11201805810PA (en) | 2018-08-30 |
Family
ID=58188714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201805810PA SG11201805810PA (en) | 2015-09-01 | 2016-07-07 | Extended, delayed and immediate release formulation method of manufacturing and use thereof |
Country Status (11)
Country | Link |
---|---|
US (2) | US20170319521A1 (en) |
EP (1) | EP3344240A4 (en) |
JP (1) | JP2018526441A (en) |
KR (1) | KR20180054655A (en) |
CN (1) | CN108135870A (en) |
AU (1) | AU2016317092A1 (en) |
HK (1) | HK1256098A1 (en) |
MX (1) | MX2018002450A (en) |
RU (1) | RU2018111400A (en) |
SG (1) | SG11201805810PA (en) |
WO (1) | WO2017039832A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114177155B (en) * | 2020-09-08 | 2023-10-03 | 越洋医药开发(广州)有限公司 | Ibuprofen controlled release tablet and preparation method thereof |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5609884A (en) * | 1992-08-31 | 1997-03-11 | G. D. Searle & Co. | Controlled release naproxen sodium plus naproxen combination tablet |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
US6126967A (en) * | 1998-09-03 | 2000-10-03 | Ascent Pediatrics | Extended release acetaminophen particles |
US20060240105A1 (en) * | 1998-11-02 | 2006-10-26 | Elan Corporation, Plc | Multiparticulate modified release composition |
US20100172983A1 (en) * | 2001-06-01 | 2010-07-08 | Plachetka John R | Pharmaceutical Compositions for the Coordinated Delivery of Naproxen and Esomeprazole |
US20040132826A1 (en) * | 2002-10-25 | 2004-07-08 | Collegium Pharmaceutical, Inc. | Modified release compositions of milnacipran |
US20050136112A1 (en) * | 2003-12-19 | 2005-06-23 | Pediamed Pharmaceuticals, Inc. | Oral medicament delivery system |
EP1789022A2 (en) * | 2004-08-31 | 2007-05-30 | Pfizer Products Incorporated | Controlled release dosage forms combining immediate release and sustained release of low-solubility drug |
CN101132769A (en) * | 2005-02-10 | 2008-02-27 | 奥瑞克索股份公司 | New pharmaceutical compositions useful in the transmucosal administration of drugs |
US20070212417A1 (en) * | 2006-03-07 | 2007-09-13 | Cherukuri S R | Compressible resilient granules and formulations prepared therefrom |
JP2010522135A (en) * | 2006-10-09 | 2010-07-01 | チャールストン ラボラトリーズ,インコーポレイテッド | Pharmaceutical composition |
BRPI0718171A2 (en) * | 2006-10-20 | 2013-11-26 | Mcneil Ppc Inc | Acetaminophen / IBUPROPHEN COMBINATIONS AND METHOD FOR USE |
US20080026054A1 (en) * | 2007-04-27 | 2008-01-31 | Nectid Inc. | Novel anelgesic combination |
US20080286343A1 (en) * | 2007-05-16 | 2008-11-20 | Dzenana Cengic | Solid form |
RU2010153904A (en) * | 2008-06-02 | 2012-07-20 | Др. Редди'С Лабораторис Лтд. (In) | Niacin-containing Compositions with Modified Release |
US20100130617A1 (en) * | 2008-11-22 | 2010-05-27 | Auspex Pharmaceuticals, Inc. | Ethanolamine modulators of nmda receptor and muscarinic acetylcholine receptor |
WO2010138441A1 (en) * | 2009-05-28 | 2010-12-02 | Aptapharma, Inc. | Multilayer oral tablets containing a non-steroidal anti-inflammatory drug and/or acetaminophen |
US9415048B2 (en) * | 2010-07-08 | 2016-08-16 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for reducing frequency of urination and method of use thereof |
US20150010599A1 (en) * | 2010-07-08 | 2015-01-08 | WELLESLEY PHARMACELJTlCALS, LLC | Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
ES2717178T3 (en) * | 2011-03-21 | 2019-06-19 | Broda Tech Co Ltd | Hydrogel compositions reversely thermoreversible |
MX2014008283A (en) * | 2012-01-04 | 2015-03-03 | Wellesley Pharmaceutical Llc | Extended-release formulation for reducing the frequency of urination and method of use thereof. |
CN103191430A (en) * | 2012-01-04 | 2013-07-10 | 韦尔斯利医药有限公司 | Sustained release preparation for relieving frequent micturition and application method thereof |
WO2013103389A1 (en) * | 2012-01-04 | 2013-07-11 | Wellesley Pharmaceuticals, Llc | Delayed-release formulation for reducing the frequency of urination and method of use thereof |
EP2841058A1 (en) * | 2012-04-23 | 2015-03-04 | Cadila Healthcare Limited | Delazed release pharmaceutical compositions of salsalate |
WO2014018223A1 (en) * | 2012-07-27 | 2014-01-30 | Wellesley Pharmaceuticals, Llc | Pharmaceutical formulation for bedwetting and method of use thereof |
TW201422254A (en) * | 2012-11-21 | 2014-06-16 | Ferring Bv | Composition for immediate and extended release |
RU2704613C2 (en) * | 2014-11-11 | 2019-10-30 | Д-Р Редди'С Лабораторис Лимитед | Pharmaceutical preparations with fixed combination of analgesic and antispasmodic agents doses |
-
2016
- 2016-07-07 CN CN201680061586.XA patent/CN108135870A/en active Pending
- 2016-07-07 SG SG11201805810PA patent/SG11201805810PA/en unknown
- 2016-07-07 EP EP16842482.8A patent/EP3344240A4/en not_active Withdrawn
- 2016-07-07 KR KR1020187009150A patent/KR20180054655A/en unknown
- 2016-07-07 JP JP2018530486A patent/JP2018526441A/en active Pending
- 2016-07-07 MX MX2018002450A patent/MX2018002450A/en unknown
- 2016-07-07 WO PCT/US2016/041352 patent/WO2017039832A1/en active Application Filing
- 2016-07-07 RU RU2018111400A patent/RU2018111400A/en not_active Application Discontinuation
- 2016-07-07 AU AU2016317092A patent/AU2016317092A1/en not_active Abandoned
-
2017
- 2017-07-05 US US15/641,713 patent/US20170319521A1/en not_active Abandoned
- 2017-07-05 US US15/641,673 patent/US20170319520A1/en not_active Abandoned
-
2018
- 2018-11-27 HK HK18115163.9A patent/HK1256098A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
HK1256098A1 (en) | 2019-09-13 |
WO2017039832A1 (en) | 2017-03-09 |
US20170319520A1 (en) | 2017-11-09 |
AU2016317092A1 (en) | 2018-04-26 |
EP3344240A4 (en) | 2019-09-04 |
MX2018002450A (en) | 2018-08-24 |
US20170319521A1 (en) | 2017-11-09 |
EP3344240A1 (en) | 2018-07-11 |
CN108135870A (en) | 2018-06-08 |
JP2018526441A (en) | 2018-09-13 |
KR20180054655A (en) | 2018-05-24 |
RU2018111400A (en) | 2019-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA201701465B (en) | Egfr inhibitor, and preparation and application thereof | |
HK1216594A1 (en) | Garment and method of manufacturing same | |
EP3299369A4 (en) | Pyrido-azaheterecydic compound and preparation method and use thereof | |
GB201514756D0 (en) | Compound and method of use | |
EP3338786C0 (en) | Shenlingbaizhu granules and preparation method thereof | |
HK1254055A1 (en) | Methods for the preparation of obeticholic acid and derivatives thereof | |
GB201514760D0 (en) | Compounds and method of use | |
EP3373910C0 (en) | Echinomycin formulation, method of making and method of use thereof | |
GB201519128D0 (en) | Solid forms and methods of preparing the same | |
IL266345A (en) | Dihydropyrimidine compound and preparation method and use thereof | |
PL3398598T3 (en) | Sulfonamide derivative and preparation method and use thereof | |
EP3207945A4 (en) | Sustained release formulation of metformin and method for preparing same | |
HK1252116A1 (en) | Free-polyunsaturated-fatty-acid-containing composition and method for manufacturing same | |
SG11201705085UA (en) | Polymer composition, its method of preparation, its use and composition comprising it | |
EP3093783A4 (en) | Terminal and method for releasing locking state of terminal | |
EP3394174A4 (en) | Composition, method of making composition, and article | |
IL254597A0 (en) | Crystalline form of ahu377, preparation method and use thereof | |
ZA201800493B (en) | Deuterated thienopiperidine derivatives, manufacturing method, and application thereof | |
HK1256098A1 (en) | Extended, delayed and immediate release formulation method of manufacturing and use thereof | |
KR102392098B9 (en) | Release film and manufacturing method thereof | |
GB201408171D0 (en) | Formulation and method of manufacture | |
EP3307251B8 (en) | Fluorocyclopentenylcytosine uses and processes of preparation | |
GB201710728D0 (en) | Set-delayed cement compositions comprising pumice and associatecd methods | |
HK1259196A1 (en) | Delayed-release formulations, methods of making and use thereof | |
ZA201708339B (en) | Primin derivatives, method of preparation thereof and use thereof |